300142.SZ
Walvax Biotechnology Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 12.16
+0.83%Forward multiples
Based on analyst estimates
- P/E forward
- 363.00x
- P/E 2026E
- 363.00x
- P/E 2027E
- 121.00x
- P/E 2028E
- 90.75x
- P/S forward
- 10.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- 109.42x
- PEG TTM
- —
- Price / book
- 2.79x
- Price / sales
- 7.26x
- Price / cash flow
- 27.54x
Enterprise value
- Enterprise value
- CNY 18.2B
- EV / sales
- 7.57x
- EV / EBITDA
- 30.83x
- EV / EBIT
- 54.60x
- Market cap
- CNY 19.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026